Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$358M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$280M |
| 4 |
NXP Semiconductors
NXPI
|
+$268M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$407M |
| 3 |
STJ
St Jude Medical
STJ
|
+$368M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
| 5 |
Apple
AAPL
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.53% |
| 2 | Energy | 3.9% |
| 3 | Technology | 3.29% |
| 4 | Healthcare | 2.41% |
| 5 | Industrials | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Ennis
EBF
$552M
| $298K | ﹤0.01% |
17,533
-21,152
| -55% | -$352K |
|
4227
First Bancorp
FBNC
$2.6B
| $298K | ﹤0.01% |
10,192
-19,987
| -66% | -$584K |
|
4228
CALL
Liberty Global Class A
LBTYA
$3.62B
| $298K | ﹤0.01% |
8,300
-241,700
| -97% | -$8.56M |
|
4229
Rollins
ROL
$18.3B
| $298K | ﹤0.01% |
18,041
-176,193
| -91% | -$2.79M |
|
4230
Virtu Financial
VIRT
$5.11B
| $298K | ﹤0.01% |
17,538
-109,511
| -86% | -$1.9M |
|
4231
CALL
Warner Bros
WBD
$65.9B
| $297K | ﹤0.01% |
10,200
+9,400
| +1,175% | +$264K |
|
|
APB
4232
DELISTED
Asia Pacific Fund
APB
| $297K | ﹤0.01% |
24,293
-3,058
| -11% | -$32.8K |
|
|
SBY
4233
DELISTED
Silver Bay Realty Trust Corp.
SBY
| $297K | ﹤0.01% |
13,849
-422,935
| -97% | -$8.05M |
|
4234
DHI Group
DHX
$182M
| $296K | ﹤0.01% |
75,031
-51,276
| -41% | -$265K |
|
4235
CALL
New Oriental
EDU
$9.37B
| $296K | ﹤0.01% |
4,900
-4,400
| -47% | -$223K |
|
|
BKCC
4236
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $296K | ﹤0.01% |
39,223
+5,418
| +16% | +$40.6K |
|
|
SRF
4237
DELISTED
THE CUSHING ROYALTY & INCOME FUND
SRF
| $296K | ﹤0.01% |
31,476
+10,870
| +53% | +$105K |
|
4238
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.1B
| $295K | ﹤0.01% |
13,954
-1,988
| -12% | -$42.7K |
|
4239
Inovio Pharmaceuticals
INO
$55.7M
| $295K | ﹤0.01% |
3,715
-10,975
| -75% | -$874K |
|
|
GBT
4240
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $295K | ﹤0.01% |
8,000
+6,000
| +300% | +$151K |
|
|
FPO
4241
DELISTED
First Potomac Realty Trust
FPO
| $295K | ﹤0.01% |
28,682
-58,389
| -67% | -$601K |
|
4242
CALL
Halozyme
HALO
$9.79B
| $294K | ﹤0.01% |
22,700
-1,000
| -4% | -$12.6K |
|
|
TIF
4243
DELISTED
Tiffany & Co.
TIF
| $294K | ﹤0.01% |
3,085
-3,957
| -56% | -$338K |
|
|
AIMT
4244
DELISTED
Aimmune Therapeutics
AIMT
| $294K | ﹤0.01% |
13,564
-35,743
| -72% | -$733K |
|
4245
Greif
GEF
$4.92B
| $293K | ﹤0.01% |
5,322
-21,770
| -80% | -$1.21M |
|
4246
TriMas Corp
TRS
$1.43B
| $293K | ﹤0.01% |
14,129
-43,231
| -75% | -$948K |
|
|
TESO
4247
DELISTED
Tesco Corp
TESO
| $293K | ﹤0.01% |
36,450
-50,619
| -58% | -$429K |
|
|
ERH
4248
Allspring Utilities & High Income Fund
ERH
$105M
| $292K | ﹤0.01% |
22,933
-400
| -2% | -$4.94K |
|
4249
PTC Therapeutics
PTCT
$5.68B
| $292K | ﹤0.01% |
29,631
-24,732
| -45% | -$299K |
|
|
TTSH
4250
DELISTED
Tile Shop Holdings
TTSH
| $292K | ﹤0.01% |
15,175
-43,498
| -74% | -$815K |
|
Similar funds
Citigroup's Q1 2017 Portfolio in Review
As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.
Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.
- Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
- Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
- Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
- Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
- Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
- Citigroup opened 332 new positions and closed 298 in Q1 2017.
- Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.
Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.